Edesa Biotech, Inc.
EDSA • NASDAQ
Edesa Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter John Weiler, with a market cap of $52.6M.
Market Cap$52.6M
Employees16.0
CEOPeter John Weiler
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ2 2026
Financials
Edesa Biotech, Inc. FAQ
Common questions about Edesa Biotech, Inc.
Edesa Biotech, Inc. is scheduled to report earnings for Q2 2026 on May 13, 2026.
Edesa Biotech, Inc. has approximately 16 employees.